Table: Fractale - 9-MTH group results

ADR Biomedical Holdings

01/02/2019 06:00

Feb 1 (Reuters)- 
             Fractale Corporation 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended       Year to 
                Dec 31, 2018        Dec 31, 2017     Mar 31, 2019 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             1.85               134 mln           3.00     
                                     (-90.4 pct)     (+474.5 pct) 
  Operating        285 mln          loss 129 mln        430 mln   
                                                     (+229.6 pct) 
  Recurring        203 mln          loss 122 mln        400 mln   
                                                     (+213.6 pct) 
  Net              222 mln             82 mln           400 mln   
                (+169.7 pct)                          (-11.1 pct) 
  EPS             33.12 yen           12.09 yen        58.90 yen  
  Ann Div                             10.00 yen        10.00 yen  
  -Q2 div            NIL                 NIL                      
  -Q4 div                             10.00 yen        10.00 yen  
  
  NOTE - Fractale Corporation. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=3750.T